Natalizumab or Fingolimod After First-Line Drugs in MS? Natalizumab or Fingolimod After First-Line Drugs in MS?

A new propensity score analysis suggests natalizumab may have the edge over fingolimod for patients who experience relapse on first-line drugs, especially patients with more active disease.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news